Literature DB >> 21854993

Ketamine infusion for sickle cell crisis pain in an adult.

Clifton G Meals, Brigit D Mullican, Christina M Shaffer, Paul F Dangerfield, Rebecca P Ramirez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21854993     DOI： 10.1016/j.jpainsymman.2011.06.003

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  7 in total

1.  Subdissociative-dose ketamine for sickle cell vaso-occlusive crisis: a narrative review for the emergency physician.

Authors:  Mohammad H Bawany; Sergey M Motov
Journal:  Clin Exp Emerg Med       Date:  2022-09-30

2.  Ketamine administration for acute painful sickle cell crisis: A randomized controlled trial.

Authors:  Mohammed S Alshahrani; Amal H AlSulaibikh; Mohamed R ElTahan; Sukayna Z AlFaraj; Laila P Asonto; Abdullah A AlMulhim; Murad F AlAbbad; Nisreen Almaghraby; Mohammed A AlJumaan; Thamir O AlJunaid; Moath N Darweesh; Faisal M AlHawaj; Alaa M Mahmoud; Bader K Alossaimi; Shaikhah K Alotaibi; Talal M AlMutairi; Duaa A AlSulaiman PharmD; Dunya Alfaraj; Reem Alhawwas; Lawrence Mbuagbaw; Kim Lewis; Madeleine Verhovsek; Mark Crowther; Gordon Guyatt; Waleed Alhazzani
Journal:  Acad Emerg Med       Date:  2021-09-21       Impact factor: 5.221

3.  Impact of Ketamine in the Management of Painful Sickle Cell Disease Vaso-Occlusive Crisis.

Authors:  Jennifer Froomkin; Randall W Knoebel; David Dickerson; Hailey Soni; Jennifer Szwak
Journal:  Hosp Pharm       Date:  2021-03-06

Review 4.  Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.

Authors:  Steven P Cohen; Anuj Bhatia; Asokumar Buvanendran; Eric S Schwenk; Ajay D Wasan; Robert W Hurley; Eugene R Viscusi; Samer Narouze; Fred N Davis; Elspeth C Ritchie; Timothy R Lubenow; William M Hooten
Journal:  Reg Anesth Pain Med       Date:  2018-07       Impact factor: 6.288

5.  Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.

Authors:  Eric S Schwenk; Eugene R Viscusi; Asokumar Buvanendran; Robert W Hurley; Ajay D Wasan; Samer Narouze; Anuj Bhatia; Fred N Davis; William M Hooten; Steven P Cohen
Journal:  Reg Anesth Pain Med       Date:  2018-07       Impact factor: 6.288

6.  Study protocol for a randomized, blinded, controlled trial of ketamine for acute painful crisis of sickle cell disease.

Authors:  Mohammed S Alshahrani; Laila Perlas Asonto; Mohamed M El Tahan; Amal H Al Sulaibikh; Sukayna Z Al Faraj; Abdullah A Al Mulhim; Murad F Al Abbad; Samar A Al Nahhash; Moath N Aldarweesh; Alaa M Mahmoud; Nisreen Almaghraby; Mohammed A Al Jumaan; Thamir O Al Junaid; Faisal M Al Hawaj; Samar AlKenany; Omaima F ElSayed; Haitham M Abdelwahab; Mohamed M Moussa; Bader K Alossaimi; Shaikah K Alotaibi; Talal M AlMutairi; Duaa A AlSulaiman; Saad D Al Shahrani; Donia Alfaraj; Waleed Alhazzani
Journal:  Trials       Date:  2019-05-27       Impact factor: 2.279

Review 7.  Ketamine for Sickle Cell Vaso-Occlusive Crises: A Systematic Review.

Authors:  Mohammed S Alshahrani; Mohannad A Alghamdi
Journal:  Saudi J Med Med Sci       Date:  2020-12-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.